QNTM

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

2.10

USD

0.00

-0.24%

Nov 06, 15:59 UTC -5

Closed

After-Market

2.12

+0.01

+0.48%

Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM) Earnings

QNTM Earnings Reports

Positive Surprise Ratio

QNTM beat 2 of 5 last estimates.

40%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Quantum Biopharma Ltd. Class B Subordinate Voting Shares earnings per share and revenue

On Nov 04, 2026, QNTM reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

INmune Bio Inc. Common stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.17

Surprise

-13.64%

Moderna, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$1.27

Actual

$0.38

Surprise

+129.79%

Vera Therapeutics, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$1.65

Actual

-$1.30

Surprise

+21.33%

Novavax Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.34

Actual

-$0.19

Surprise

+44.56%

Eton Pharmaceutcials, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.31

Actual

$1.06

Surprise

+232.50%

Castle Biosciences, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.13

Surprise

+65.32%

Monte Rosa Therapeutics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.29

Actual

$0.03

Surprise

+110.09%

PUMA BIOTECHNOLOGY INC

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.09

Actual

$0.15

Surprise

+63.40%

Allogene Therapeutics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.15

Actual

-$0.15

Surprise

+0.33%

Arcturus Therapeutics Holdings Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.69

Actual

-$0.26

Surprise

+62.44%

FAQ

What were Quantum Biopharma Ltd. Class B Subordinate Voting Shares's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Quantum Biopharma Ltd. Class B Subordinate Voting Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Quantum Biopharma Ltd. Class B Subordinate Voting Shares's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Quantum Biopharma Ltd. Class B Subordinate Voting Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Quantum Biopharma Ltd. Class B Subordinate Voting Shares's next earnings report?

Based on -- analysts, Quantum Biopharma Ltd. Class B Subordinate Voting Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.